$ 143.75+0.64 (+0.45%)
AperturaPrecio de apertura
—MínimoPrecio mínimo de hoy
—Máximo de 52 semanasMáximo en 52 semanas
—MáximoPrecio máximo de hoy
—Mínimo de 52 semanasMínimo en 52 semanas
—Cap. de mercadoValor total de la empresa
272.01BVolumen de hoyAcciones negociadas hoy
1.53MVolumen promedioPromedio de acciones negociadas
2.05MRelación P/ERelación precio-beneficio
21.52Perfil de la empresa
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Fecha de salida a bolsa
1996-11-07Sede
Basel, CHCEO
Vasant NarasimhanSector
HealthcareIndustria
Drug Manufacturers - GeneralEstados financieros
Resultados
Noticias

Ionis Delivers Positive Late-Stage Results for Two Partnered Drugs
16 days agoNVSzacks.com

Celldex Prepares For 2027 FDA Submission for Chronic Skin Disease
17 days agoNVSbenzinga.com

NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
18 days agoNVSzacks.com

Critical Analysis: Redhill Biopharma (NASDAQ:RDHL) versus Novartis (NYSE:NVS)
19 days agoNVSdefenseworld.net

Novartis halts ALS drug development after mid-stage trial failure
23 days agoNVSreuters.com

VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?
24 days agoNVSfool.com
Noticias
Empresas relacionadas
ABBVAbbVie Inc.
276.47
AZNAstraZeneca PLC
159.20
BMYBristol-Myers Squibb Company
59.12
GILDGilead Sciences, Inc.
151.17














